Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

October 28, 2024 Cover

Volume 102, Issue 34

The drug industry may finally phase out using horseshoe crab blood. What took so long?

Full Article
Volume 102 | Issue 34

All Issues

Quote of the Week

“Every human who has medical intervention has benefited from horseshoe crabs.”

Glenn Gauvry, president, Ecological Research and Development Group

  • Periodic Graphics: Porphyria and the vampirism myth

    Chemical educator and Compound Interest blogger Andy Brunning pokes holes in the idea that the heme-related disorders inspired the concept of vampires.

  • Regulatory RNA could be the secret to a rare neurodevelopmental disorder

    Having too much or too little CHD2 is problematic

  • Data missing for many personal care ingredients

    Industry-led report identifies high-priority chemicals to eliminate or characterize

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT